1887

Abstract

The immunosuppressant rapamycin can regulate the translation of a subset of messenger RNAs, a phenotype which has been linked to the presence of a polypyrimidine motif [C(N)] downstream of the mRNA cap structure. T-cell clones naturally infected with transcriptionally active human T-cell leukaemia virus, type I (HTLV-I) undergo autologous proliferation; this phenotype is inhibited by rapamycin but not FK506, which reverses the rapamycin effect. Within the R region of the HTLV-I 5′ long terminal repeat (LTR) there are seven polypyrimidine motifs. We sought to determine if these were involved in the sensitivity of proliferation to the presence of rapamycin. Here we illustrate the generation of an model of this rapamycin-sensitivity and the analysis of LTR mutants which were created to determine the importance of the polypyrimidine motifs. Reporter gene assays suggest the effect is independent of the polypyrimidine motifs in the virus leader sequence.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-2-435
2001-02-01
2020-05-26
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/2/0820435a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-2-435&mimeType=html&fmt=ahah

References

  1. Abraham R., Wiederrecht G.. 1996; Immunopharmacology of rapamycin. Annual Reviews in Immunology14:483–510
    [Google Scholar]
  2. Brown E., Schreiber S.. 1996; A signaling pathway to translational control. Cell86:517–520
    [Google Scholar]
  3. Brown E., Beal P., Keith C., Chen J., Shin T., Schreiber S.. 1995; Control of p70 S6 kinase by kinase activity of FRAP in vivo . Nature377:441–446
    [Google Scholar]
  4. Brunn G., Williams J., Sabers C., Wiederrecht G., Lawrence J. Jr, Abraham R.. 1996; Direct inhibition of the signalling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO Journal15:5256–5267
    [Google Scholar]
  5. Chen Y.-G., Liu F., Massagué J.. 1997; Mechanism of TGFβ receptor inhibition by FKBP12. EMBO Journal16:3866–3876
    [Google Scholar]
  6. Choi J., Chen J., Schreiber S., Clardy J.. 1996; Structure of the FKBP12–rapamycin complex interacting with the binding domain of human FRAP. Science273:239–242
    [Google Scholar]
  7. Flint J., Shenk T.. 1997; Viral transactivating proteins. Annual Review of Genetics31:177–212
    [Google Scholar]
  8. Höllsberg P., Wucherpfennig K., Ausubel L., Calvo V., Bierer B., Hafler D.. 1992; Characterization of HTLV-I in vivo infected T cell clones. Journal of Immunology148:3256–3263
    [Google Scholar]
  9. Jeffries H., Fumagalli S., Dennis P., Reinhard C., Pearson R., Thomas G.. 1997; Rapamycin suppresses 5′ TOP mRNA translation through inhibition of p70s6k. EMBO Journal16:3693–3704
    [Google Scholar]
  10. Kunkel T., Roberts J., Zakour R.. 1987; Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods in Enzymology154:367–382
    [Google Scholar]
  11. Levy S., Avni D., Hariharan N., Perry R., Meyuhas O.. 1991; Oligopyrimidine tract at the 5′ end of mammalian ribosomal protein mRNAs is required for their translational control. Proceedings of the National Academy of Sciences, USA88:3319–3323
    [Google Scholar]
  12. Mendez R., Myers M., White M., Rhoads R.. 1996; Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation and PHAS-1 phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Molecular and Cellular Biology16:2857–2864
    [Google Scholar]
  13. Mesnard J.-M., Devaux C.. 1999; Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 tax protein. Virology257:277–284
    [Google Scholar]
  14. Nielsen F., Østergaard L., Niesene J., Christiansen J.. 1995; Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature377:358–362
    [Google Scholar]
  15. Pause A., Belsham G. J., Gingras A. C., Donze O., Lin T. A., Lawrence J. C. Jr, Sonenberg N.. 1994; Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature371:762–767
    [Google Scholar]
  16. Rose N., Richardson J., Desselberger U., Lever A.. 2000; Virus inactivation in a proportion of human T-cell leukaemia virus type I-infected T-cell clones arises through naturally occurring mutations. Journal of General Virology81:97–104
    [Google Scholar]
  17. Sambrook J., Fritsch E., Maniatis T.. 1989; Molecular Cloning: A Laboratory Manual , 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  18. Scott P. H., Brunn G. J., Kohn A. D., Roth R. A., Lawrence J.. C. Jr(1998; Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling. Proceedings of the National Academy of Sciences, USA95:7772–7777
    [Google Scholar]
  19. Sehgal S.. 1998; Rapamune (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clinical Biochemistry31:335–340
    [Google Scholar]
  20. Sodroski J., Rosen C., Haseltine W.. 1984; Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science225:381–385
    [Google Scholar]
  21. Terada N., Patel H., Takase K., Kohno K., Nairn A.. 1994; Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proceedings of the National Academy of Sciences, USA91:11477–11481
    [Google Scholar]
  22. Wucherpfennig K., Höllsberg P., Richardson J., Benjamin D., Hafler D.. 1992; T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proceedings of the National Academy of Sciences, USA89:2110–2114
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-2-435
Loading
/content/journal/jgv/10.1099/0022-1317-82-2-435
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error